Jefferies Financial Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
LCM
Jefferies Financial Group's CCCC Position: Q3 2026 in Review
Jefferies Financial Group opened a new position in C4 Therapeutics (CCCC) in Q3 2026: 10,080 shares worth $33.6K. The stake represents ﹤0.01% of the portfolio and ranks #1235 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in CCCC as recently as Q1 2026.
Jefferies Financial Group first reported a position in CCCC in Q3 2025 and has held it in 4 quarters since. The position peaked at $84.8K in Q3 2025. 151 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- Jefferies Financial Group held 10,080 shares of C4 Therapeutics worth $33.6K as of Q3 2026.
- C4 Therapeutics was a new Jefferies Financial Group position in Q3 2026.
- C4 Therapeutics made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1235 holding.
- Jefferies Financial Group first reported a position in C4 Therapeutics in Q3 2025 and has held it in 4 quarters since.
- Jefferies Financial Group's C4 Therapeutics position peaked at $84.8K in Q3 2025.
- 151 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.